Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia
Background. Current chemotherapy protocols for T-cell acute lymphoblastic leukemia (T-ALL) allow achieving a 5-year overall survival of 60–90 %, but relapsed and refractory forms remain incurable situations.Aim. To determine the significance of immunophenotypic, cytogenetic and molecular markers in...
Saved in:
| Main Authors: | A. N. Vasileva, O. A. Aleshina, E. S. Kotova, B. V. Biderman, T. N. Obukhova, I. V. Galtseva, V. N. Dvirnyk, E. I. Zakharko, A. B. Sudarikov, E. N. Parovichnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/920 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review
by: A. N. Vasileva, et al.
Published: (2022-11-01) -
Polymorphisms of the <i>TPMT</i>, <i>NUDT15</i> genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
by: E. S. Kotova, et al.
Published: (2022-07-01) -
Features of cytogenetic diagnosis of simultaneous chronic lymphocytic leukemia and myelodysplastic syndrome: clinical case report
by: M. A. Kislitsyna, et al.
Published: (2019-10-01) -
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
by: I. S. Piskunova, et al.
Published: (2017-10-01) -
Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)